Balancing thromboembolism and bleeding risks: Insights from anticoagulation for prosthetic heart valves

Chest

Volumn 136, Issue 6, 2009, Pages 1451-1452

  Tay, Kok Hoon ^a   Lane, Deirdre A ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

ADD ON THERAPY; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ATHEROSCLEROSIS; BLEEDING; CARDIOVASCULAR RISK; DRUG MEGADOSE; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MITRAL VALVE REPLACEMENT; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK MANAGEMENT; STROKE; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOSIS PREVENTION; TREATMENT DURATION;

EID: 73149122343     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1187     Document Type: Editorial

References (10)

1. Edmunds LH Jr. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987; 44:430-445
2. Edmunds LH Jr. Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 1982; 34:96-106
3. Salem DN, O'Gara PT, Madias C, et al. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(suppl):593S-629S
4. Le Tourneau T, Lim V, Inamo J, et al. Achieved anticoagulation versus prosthesis selection for mitral mechanical valve replacement: a population-based outcome study. Chest 2009; 136:1503-1513
5. Lane DA, Ponsford J, Shelley A, et al. Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme: the West Birmingham Atrial Fibrillation Project. Int J Cardiol 2006 28; 110:354-358
6. Dahri K, Loewen P. The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules. Thromb Haemost 2007; 98:980-987
7. Tay KH, Lane DA, Lip GYH. Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin? Thromb Haemost 2008; 100:955-957
8. Miller MM, Hipp R, Matsumura ME. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation. Interact Cardiovasc Thorac Surg 2008; 7:1167-1169
9. Hughes M, Lip GY, Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 2008; 99:295-304
10. McBane RD, Hodge DO, Wysokinski WE. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. Thromb Haemost 2008; 99:951-955